{
    "Trade/Device Name(s)": [
        "BD ProbeTec Chlamydia trachomatis (CT) Q Amplified DNA Assay",
        "BD ProbeTec CT Q Amplified DNA Assay",
        "BD ProbeTecTM Chlamydia trachomatis (CT) Q Amplified DNA Assay",
        "BD ProbeTec CT Qx Amplified DNA Assay",
        "BD ProbeTec CT Q* Amplified DNA Assay",
        "BD ProbeTecM Chlamydia trachomatis (CT) Q Amplified DNA Assay"
    ],
    "Submitter Information": "BD Diagnostic Systems (Becton, Dickinson and Company)",
    "510(k) Number": "K081824",
    "Predicate Device Reference 510(k) Number(s)": [
        "K984631",
        "K003395"
    ],
    "Regulatory Class": "Class I",
    "Product Code(s)": [
        "MKZ"
    ],
    "Summary Letter Date": "December 5, 2008",
    "Summary Letter Received Date": "December 9, 2008",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 866.3120"
    ],
    "Regulation Name(s)": [
        "Chlamydia Serological Reagents"
    ],
    "Analyte Class(es)": [
        "microbiology",
        "virology"
    ],
    "Analyte(s)": [
        "Chlamydia trachomatis DNA"
    ],
    "Specimen Type(s)": [
        "Female endocervical swab",
        "Male urethral swab",
        "Vaginal swab",
        "Urine"
    ],
    "Specimen Container(s)": [
        "BD ProbeTec Q UPT urine specimen collection device",
        "Swab",
        "Urine collection device"
    ],
    "Instrument(s)/Platform(s)": [
        "BD Viper System",
        "Thermally-controlled fluorescent readers"
    ],
    "Method(s)/Technology(ies)": [
        "Strand Displacement Amplification (SDA)",
        "Nucleic acid amplification",
        "DNA probe",
        "Fluorescent detection"
    ],
    "Methodologies": [
        "Nucleic acid amplification testing (NAAT)",
        "Qualitative detection",
        "Automated extraction"
    ],
    "Submission Type(s)": [
        "Assay",
        "Reagent",
        "System"
    ],
    "Document Summary": "FDA 510(k) summary for BD ProbeTec Chlamydia trachomatis Q Amplified DNA Assay, a nucleic acid amplification test for direct qualitative detection of C. trachomatis DNA in swab and urine specimens using the BD Viper System",
    "Indications for Use Summary": "Qualitative detection of Chlamydia trachomatis DNA in female endocervical and male urethral swabs, patient-collected vaginal swabs, and urine specimens from asymptomatic and symptomatic individuals to aid diagnosis of chlamydial urogenital disease",
    "fda_folder": "Microbiology"
}